RAVI SALGIA joined City of Hope as a professor and chair of the Department of Medical Oncology & Therapeutics Research.
RAFAT ABONOUR was appointed medical liaison for the International Myeloma Foundation, to support the group's European program expansion.
DEAN TSARWHAS was named medical director of cancer services for Northwestern Medicine's Lake Forest Hospital and Grayslake Outpatient Center. Previously, Tsarwhas treated oncology patients in private practice. He has also been on staff at Lake Forest Hospital.
PAUL KLUETZ was appointed associate director of clinical science in the FDA Office of Hematology Oncology Products, effective Jan. 24.
AMY MCKEE was appointed acting deputy office director in the FDA Office of Hematology Oncology Products.
ST. JUDE CHILDREN'S RESEARCH HOSPITAL has received a unanimous vote of approval from the Tennessee Higher Education Commission for the opening of a new graduate school of biomedical sciences.
ST. JUDE announced a $20-million commitment from The Steven & Alexandra Cohen Foundation to support inpatient care. The Cohen Foundation's gift will help fund the construction of an inpatient care unit for children treated at the new Kay Research & Care Center on the St. Jude campus.
INOVA and George Mason University formed a partnership to conduct translational research. The partnership was announced by Virginia Gov. Terry McAuliffe.
MEMORIAL SLOAN KETTERING CANCER CENTER opened its Josie Robertson Surgery Center. At full capacity, the outpatient center will accommodate 60 surgeries a day.
RESEARCH!AMERICA unveiled its policy wish list for 2016, urging Congress to take action on several research priorities.